UNSPSC 51382300: Nonsteroidal anti inflammatory benzoic acids

Nonsteroidal anti inflammatory drugs made from benzoic acid derivatives, hence the terms BENZOATE or BENZOATES, which may include acid forms, salts, esters, and amides that contain the carboxybenzene structure.

UNSPSC 51382300 Nonsteroidal anti-inflammatory benzoic acids, a Class code, shows little relevant recent procurement activity under its nominal scope. The three most recent state and local opportunities tagged to this code involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and over-the-counter products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). None of these acquisitions align with nonsteroidal anti-inflammatory benzoic acids as a discrete pharmaceutical category; the tagging appears to reflect broader pharmaceutical procurement classifications rather than the specific active-ingredient or chemical-class taxonomy the code nominally describes. The issuing bodies include a county health department, a state health commission, and a multistate cooperative purchasing entity, reflecting the diversity of government procurement structures, but the actual products sought diverge substantially from the code's stated scope.

Activity is geographically dispersed across Florida, Texas, and Minnesota, with the cooperative purchasing vehicle serving multiple states including Oregon. The Seminole County IFB (Solicitation IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas HHS RFI (HHS0017013, posted April 3, 2026) gathered market intelligence on direct-to-manufacturer prescription fulfillment models; and the MMCAP RFP (S1070000015802, due March 26, 2026) established multi-vendor contracts for generic pharmaceuticals and OTC products across state and local facilities. State and local procurement under this code does not reflect the specific benzoic-acid nonsteroidal anti-inflammatory class. The mismatch between the code's nominal scope and recent solicitations suggests this code may not be the appropriate taxonomy for substantive business development activity in this category.